Article
Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models.
Neurobiology of disease - 1 Nov 2024
Salem Shireen, Alpaugh Melanie, Saint-Pierre Martine, Alves-Martins-Borba Flavia Natale, Cerquera-Cleves Catalina, Lemieux Mado, Ngonza-Nito Soki Bradel, De Koninck Paul, Melki Ronald, Cicchetti Francesca
Abstract excerpt
There is now compelling evidence for the presence of pathological forms of Tau in tissues of both patients and animal models of Huntington's disease (HD). While the root cause of this illness is a mutation within the huntingtin gene, a number of studies now suggest that HD could also be considered a secondary tauopathy. However, the contributory role of Tau in the pathogenesis and pathophysiology of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
